176 related articles for article (PubMed ID: 2887430)
1. Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study.
Eur Heart J; 1987 Jun; 8(6):634-42. PubMed ID: 2887430
[TBL] [Abstract][Full Text] [Related]
2. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
Lancet; 1992 Mar; 339(8796):753-70. PubMed ID: 1347801
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
Lancet; 1988 Aug; 2(8607):349-60. PubMed ID: 2899772
[TBL] [Abstract][Full Text] [Related]
4. [A randomized study of streptokinase and recombinant tissue plasminogen activator, with and without heparin, in patients with acute myocardial infarction. The results of GISSI-2/International tPA/SK Mortality Trial].
Steffensen R; Sandøe E
Ugeskr Laeger; 1991 Oct; 153(41):2880-3. PubMed ID: 1949301
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):3A-13A. PubMed ID: 2903874
[TBL] [Abstract][Full Text] [Related]
6. [Systemic thrombolysis using streptokinase. Experiences at the Civic Hospital of Lugano in the framework of the ISIS-2 study].
Moccetti T; Rezzonico M; Clara F; Riva A; Tanzi F; Genoni M; Malacrida R
Schweiz Med Wochenschr; 1988 Nov; 118(46):1702-5. PubMed ID: 3212423
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
[TBL] [Abstract][Full Text] [Related]
8. Six-month survival in 20,891 patients with acute myocardial infarction randomized between alteplase and streptokinase with or without heparin. GISSI-2 and International Study Group. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto.
Eur Heart J; 1992 Dec; 13(12):1692-7. PubMed ID: 1289101
[TBL] [Abstract][Full Text] [Related]
9. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
10. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico.
Lancet; 1990 Jul; 336(8707):65-71. PubMed ID: 1975321
[TBL] [Abstract][Full Text] [Related]
11. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Second Chinese Cardiac Study (CCS-2) Collaborative Group
J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
[TBL] [Abstract][Full Text] [Related]
12. [Reduction of mortality in acute myocardial infarction with streptokinase and aspirin therapy. Results of ISIS-2].
Madsen JK; Pedersen F; Amtoft A; Deding A; Grande P; Hansen JN; Hilden M; Hornum I; Jensen T; Lindskov J
Ugeskr Laeger; 1989 Oct; 151(40):2565-9. PubMed ID: 2683281
[TBL] [Abstract][Full Text] [Related]
13. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
[TBL] [Abstract][Full Text] [Related]
14. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials.
Eikelboom JW; Quinlan DJ; Mehta SR; Turpie AG; Menown IB; Yusuf S
Circulation; 2005 Dec; 112(25):3855-67. PubMed ID: 16344381
[TBL] [Abstract][Full Text] [Related]
15. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
[TBL] [Abstract][Full Text] [Related]
16. [Intravenous streptokinase in acute myocardial infarction. Reduction of early in-hospital mortality].
Cortadellas J; Figueras J; Curos A; Cinca J; Moya A; Angel J; Salas A; Roma F
Rev Esp Cardiol; 1989 Apr; 42(4):254-61. PubMed ID: 2781119
[TBL] [Abstract][Full Text] [Related]
17. Aspirin, heparin, or both to treat acute unstable angina.
Théroux P; Ouimet H; McCans J; Latour JG; Joly P; Lévy G; Pelletier E; Juneau M; Stasiak J; deGuise P
N Engl J Med; 1988 Oct; 319(17):1105-11. PubMed ID: 3050522
[TBL] [Abstract][Full Text] [Related]
18. [ISIS-2, an international study of survival after a heart infarct: the power of large numbers?].
Koster RW
Ned Tijdschr Geneeskd; 1989 Feb; 133(7):338-40. PubMed ID: 2648174
[No Abstract] [Full Text] [Related]
19. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
Baigent C; Collins R; Appleby P; Parish S; Sleight P; Peto R
BMJ; 1998 May; 316(7141):1337-43. PubMed ID: 9563981
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous streptokinase versus heparin in recent acute myocardial infarction. Randomized multicenter study in the Franche-Comté].
Bassand JP; Faivre R; Becqué O; Habert C; Schuffenecker M; Petiteau PY; Cardot JC; Verdenet J; Laroze M; Maurat JP
Arch Mal Coeur Vaiss; 1986 Apr; 79(4):421-8. PubMed ID: 3090959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
